SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
International society for pharmacoeconomics and outcomes research
0 references·11 citing·40 second hop
International society for pharmacoeconomics and outcomes research (2006)International society for pharmacoeconomi…Resource Allocation and Priority Setting in Health Care: A Multi‐criteria Decision Analysis Problem of Value? (2016)Resource Allocation and Prior…Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers (2014)Current Status and Trends in …A Review and Meta-analysis of Colorectal Cancer Utilities (2014)A Review and Meta-analysis of…Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer (2013)Cost–Utility Analysis of the …Acknowledging Patient Heterogeneity in Economic Evaluation (2013)Acknowledging Patient Heterog…Health Technology Funding Decision-Making Processes Around the World (2011)Health Technology Funding Dec…Eliciting Benefit–Risk Preferences and Probability-Weighted Utility Using Choice-Format Conjoint Analysis (2011)Eliciting Benefit–Risk Prefer…Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis (2010)Accounting for the Drug Life …Valuing Health States for Use in Cost-Effectiveness Analysis (2008)Valuing Health States for Use…Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada (2008)Guidelines for Conducting Pha…Too Important to Ignore (2006)Too Important to IgnoreCost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Decision Modelling For Health Economic Evaluation (2006)Gross Domestic Product (1994)Early appraisal of China's huge and complex health-care reforms (2012)The Handbook of Research Synthesis. (1995)Cochrane Handbook for Systematic Reviews of Interventions (2008)A systematic review of coverage decision-making on health technologies—Evidence from the real world (2012)Social values and health priority setting in Australia: An analysis applied to the context of health technology assessment (2014)Applications of the Capability Approach in the Health Field: A Literature Review (2016)Doing Qualitative Research (2017)Systematic Overview of Cost-Utility Assessments in Oncology (2000)A Meta-Analysis of Quality-of-Life Estimates for Stroke (2003)Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values? (2015)Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial (2020)EuroQol: the current state of play (1996)A review of health utilities across conditions common in paediatric and adult populations (2010)Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries (2016)Age- and sex-specific Canadian utility norms, based on the 2013–2014 Canadian Community Health Survey (2018)Economic valuation of informal care (2004)Informal care and health care use of older adults (2004)The invisible hands made visible: recognizing the value of informal care in healthcare decision-making (2008)Evidence of Spillover of Illness among Household Members (2012)Measuring Family HRQoL Spillover Effects Using Direct Health Utility Assessment (2014)Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers (2010)Centers for Medicare & Medicaid Services (CMS) (2013)Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force (2013)Implementing managed entry agreements in practice: The Dutch reality check (2018)The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments (2019)Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies (2020)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007 (2010)Budget impact analysis in economic evaluation: a proposal for a clearer definition (2011)Prospect Theory: An Analysis of Decision under Risk (1979)Prospect theory: An analysis of decision under risk (1988)Theory of games and economic behavior (2019)A Theory of Justice (1971)Multiple Criteria Decision Analysis: An Integrated Approach (2001)A two-stage fuzzy optimization model for scarce drugs supply and ration planning under uncertainty: A case study (2019)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2008Valuing Health States for Use in Cost-Effectiveness Analysis92 cited
  • 2011Health Technology Funding Decision-Making Processes Around the World84 cited
  • 2008Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada80 cited
  • 2013Acknowledging Patient Heterogeneity in Economic Evaluation70 cited
  • 2016Resource Allocation and Priority Setting in Health Care: A Multi‐criteria Decision Analysis Problem of Value?67 cited
  • 2014Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers66 cited
  • 2011Eliciting Benefit–Risk Preferences and Probability-Weighted Utility Using Choice-Format Conjoint Analysis66 cited
  • 2006Too Important to Ignore60 cited
  • 2014A Review and Meta-analysis of Colorectal Cancer Utilities57 cited
  • 2013Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer53 cited
  • 2010Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work